Clinical Trial Update: Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mupirocin to reduce Staphylococcus aureus colonization in infants in a NICU; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Colonization in Infants
• Staphylococcus Aureus Infection Risk in Neonates

Drugs mentioned

• Mupirocin (Mupirocin)

Snippet

Sponsor: Crouse Hospital | Conditions: Staphylococcus | Phase 2 | Status: COMPLETED